| Reduced availability of voltage‐gated sodium channels by depolarization or blockade by tetrodotoxin boosts burst firing and catecholamine release in mouse chromaffin cells DHF Vandael, MM Ottaviani, C Legros, C Lefort, NC Guérineau, A Allio, ... The Journal of physiology 593 (4), 905-927, 2015 | 59 | 2015 |
| Trikafta rescues CFTR and lowers monocyte P2X7R-induced inflammasome activation in cystic fibrosis C Gabillard-Lefort, M Casey, AMA Glasgow, F Boland, O Kerr, E Marron, ... American journal of respiratory and critical care medicine 205 (7), 783-794, 2022 | 34 | 2022 |
| A review of alpha-1 antitrypsin binding partners for immune regulation and potential therapeutic application ME O’Brien, G Murray, D Gogoi, A Yusuf, C McCarthy, MR Wormald, ... International Journal of Molecular Sciences 23 (5), 2441, 2022 | 34 | 2022 |
| Effect of elexacaftor/tezacaftor/ivacaftor on airway and systemic inflammation in cystic fibrosis M Casey, C Gabillard-Lefort, OF McElvaney, OJ McElvaney, T Carroll, ... Thorax 78 (8), 835-839, 2023 | 28 | 2023 |
| Monitoring the secretory behavior of the rat adrenal medulla by high-performance liquid chromatography-based catecholamine assay from slice supernatants F De Nardi, C Lefort, D Bréard, P Richomme, C Legros, NC Guérineau Frontiers in endocrinology 8, 248, 2017 | 23 | 2017 |
| Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implications OF McElvaney, T Asakura, SL Meinig, JL Torres-Castillo, RS Hagan, ... EBioMedicine 77, 2022 | 22 | 2022 |
| Stimulation of P2Y11 receptor protects human cardiomyocytes against Hypoxia/Reoxygenation injury and involves PKCε signaling pathway L Benoist, S Chadet, T Genet, C Lefort, A Heraud, MD Danila, ... Scientific Reports 9 (1), 11613, 2019 | 21 | 2019 |
| Stimulation of P2Y11 receptor modulates cardiac fibroblasts secretome toward immunomodulatory and protective roles after Hypoxia/Reoxygenation injury C Lefort, L Benoist, S Chadet, M Piollet, A Heraud, D Babuty, C Baron, ... Journal of Molecular and Cellular Cardiology 121, 212-222, 2018 | 19 | 2018 |
| Modulation of P2Y11-related purinergic signaling in inflammation and cardio-metabolic diseases MD Dănilă, M Piollet, OM Aburel, D Angoulvant, C Lefort, S Chadet, ... European Journal of Pharmacology 876, 173060, 2020 | 11 | 2020 |
| P2y11 agonism prevents hypoxia/reoxygenation-and angiotensin II-induced vascular dysfunction and intimal hyperplasia development M Piollet, A Sturza, S Chadet, C Gabillard-Lefort, L Benoist, DM Muntean, ... International Journal of Molecular Sciences 22 (2), 855, 2021 | 8 | 2021 |
| Current evidence on the effect of highly effective CFTR modulation on interleukin-8 in cystic fibrosis M Williamson, M Casey, C Gabillard-Lefort, A Alharbi, YQJ Teo, ... Expert Review of Respiratory Medicine 16 (1), 43-56, 2022 | 6 | 2022 |
| In vitro and in vivo modulation of NADPH oxidase activity and reactive oxygen species production in human neutrophils by α1-antitrypsin P Hawkins, T McEnery, C Gabillard-Lefort, DA Bergin, B Alfawaz, ... ERJ Open Research 7 (4), 2021 | 4 | 2021 |
| Reduced availability of Nav channels by depolarization or block by TTX boosts burst firing and catecholamine release in mouse chromaffin cells DHF Vandael, MM Ottaviani, C Legros, C Lefort, NC Guérineau, A Allio, ... J. Physiol 593, 905-927, 2015 | 3 | 2015 |
| The impact of elexacaftor/tezacaftor/ivacaftor on the protease-antiprotease balance in cystic fibrosis airways M Casey, C Gabillard-Lefort, D Fraughen, M Herron, MP Murphy, O Kerr, ... A40. INVESTIGATIONS IN CYSTIC FIBROSIS AND NON-CF BRONCHIECTASIS, A1465-A1465, 2022 | 1 | 2022 |
| 550: Effect of elexacaftor/tezacaftor/ivacaftor on LPS-and ATP-induced inflammasome activation in monocytes of patients with cystic fibrosis C Gabillard-Lefort, M Casey, C Gunaratnam, E Reeves, N McElvaney Journal of Cystic Fibrosis 20, S260, 2021 | 1 | 2021 |
| CFTR Modulator Therapy Rescues CFTR and Lowers P2X7R-induced Inflammasome Activation of Airway Epithelial Cells D Gogoi, M Casey, C Bolger, S Alghamdi, P Acquilini, L D’Costa, R Baird, ... ERJ Open Research 9 (suppl 12), 2023 | | 2023 |
| WS18. 02 ETI triple therapy shows sustained, progressive normalisation of airway cytokine and antiprotease balance and systemic inflammation over one year of treatment MP Murphy, M Casey, C Gabillard-Lefort, OF McElvaney, OJ McElvaney, ... Journal of Cystic Fibrosis 22, S34, 2023 | | 2023 |
| SUPPLEMENTARY METHODOLOGY M Casey, C Gabillard-Lefort, OF McElvaney, OJ McElvaney, TP Carroll, ... Thorax 835, 78, 2023 | | 2023 |
| Decreased anti-neutrophil cytoplasmic autoantibodies (ANCA) against bactericidal/permeability-increasing (BPI) post CFTR modulator therapy D Gogoi, M Casey, A Yusuf, C Gabillard-Lefort, C Gunaratnam, ... IRISH JOURNAL OF MEDICAL SCIENCE 191, S160-S161, 2022 | | 2022 |
| The CFTR modulator combination elexacaftor/tezacaftor/ivacaftor restores CFTR protein expression in circulating neutrophils of patients with cystic fibrosis A Yusuf, M Casey, D Gogoi, C Gabillard-Lefort, C Gunaratnam, ... IRISH JOURNAL OF MEDICAL SCIENCE 191, S160-S160, 2022 | | 2022 |
